News
1h
News Medical on MSNReelin marks cocaine-activated brain neurons and regulates cocaine rewardIn a study published in Science Advances, University of Alabama at Birmingham researchers led by Kasey Brida and Jeremy Day, ...
16h
AZoLifeSciences on MSNPrime Editing Enters the Clinic: A CRISPR Milestone for Rare Immune DisordersClustered, regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated protein 9 (CRISPR-Cas9) are genome ...
5d
Zacks Investment Research on MSNBEAM Up on FDA's Orphan Drug Status for Gene-Editing TherapyBeam Therapeutics BEAM announced that the FDA has granted an orphan drug designation to its investigational genome-editing ...
Shares lost a quarter of their value after the company disclosed, in a regulatory filing, signs of liver stress in a study ...
Scientists have used personalised gene-editing therapy to successfully treat a baby with a rare genetic condition. Could this ...
Gene therapy experts and advocates warning of the sector’s many challenges found a receptive audience in FDA leadership at a ...
This research roundup discusses researchers’ attempts to find a treatment for a “brain fog” that comes with CAR T-Cell ...
A baby born with a rare and dangerous genetic disease is growing and thriving after getting an experimental gene editing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results